looks like the market is viewing this as neutral to positiveno huge exit and even some buyingso:NON exclusive license to Bayer - leaving the market open for other playersI just wonder...........................
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025